
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
Steven R Feldman, professor of Dermatology and Director of the Center for Dermatology Research at Wake Forest Baptist Health, discusses the need to advise parents and patients about proper protection from the sun.
Steven R Feldman, professor of Dermatology and Director of the Center for Dermatology Research at Wake Forest Baptist Health, discusses the need to advise parents and patients about proper protection from the sun.






